STOCK TITAN

Omada Health (OMDA) CAO sells 2,083 shares under 10b5-1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Omada Health, Inc. Chief Accounting Officer Craig Gracey reported an open-market sale of common stock. On June 24, 2026, she sold 2,083 shares at a weighted average price of $19.0118 per share. The transaction was made under a Rule 10b5-1 trading plan adopted on March 13, 2026, and she now directly holds 5,025 shares of Omada Health common stock.

Positive

  • None.

Negative

  • None.

Insights

Pre-planned, modest open-market sale with shares retained.

Chief Accounting Officer Craig Gracey executed an open-market sale of 2,083 shares of Omada Health, Inc. common stock at a weighted average price of $19.0118 on June 24, 2026.

The filing notes the sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026, indicating it was pre-scheduled rather than opportunistic. After the sale, Gracey continues to hold 5,025 shares directly, showing an ongoing equity stake.

Because this is a single, relatively small open-market sale under a pre-arranged plan, it typically carries limited signaling value about the company’s outlook. Future company filings may update her holdings if additional plan transactions occur.

Insider Gracey Craig
Role Chief Accounting Officer
Sold 2,083 shs ($40K)
Type Security Shares Price Value
Sale Common Stock 2,083 $19.0118 $40K
Holdings After Transaction: Common Stock — 5,025 shares (Direct, null)
Footnotes (1)
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares sold 2,083 shares Open-market sale on June 24, 2026
Weighted average sale price $19.0118 per share Common stock, multiple trades between $19.00 and $19.03
Shares held after transaction 5,025 shares Direct ownership by Craig Gracey post-sale
Net shares sold 2,083 shares Net-sell direction in transaction summary
10b5-1 plan adoption date March 13, 2026 Date Gracey adopted Rule 10b5-1 trading plan
Rule 10b5-1 trading plan financial
"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gracey Craig

(Last)(First)(Middle)
C/O OMADA HEALTH, INC.
611 GATEWAY BLVD, SUITE 120

(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/24/2026S(1)2,083D$19.0118(2)5,025D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
2. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Nathan Salha, as Attorney-in-Fact for Craig Gracey06/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Omada Health (OMDA) report for Craig Gracey?

Omada Health reported that Chief Accounting Officer Craig Gracey sold 2,083 shares of common stock. The transaction was an open-market sale executed on June 24, 2026, under a pre-arranged Rule 10b5-1 trading plan adopted earlier in March 2026.

At what price did Omada Health’s CAO sell shares in the latest Form 4?

Craig Gracey sold 2,083 Omada Health shares at a weighted average price of $19.0118. The filing notes trades occurred between $19.00 and $19.03, with the reported figure reflecting the weighted average across multiple executions that day.

How many Omada Health (OMDA) shares does Craig Gracey hold after this sale?

Following the reported transaction, Craig Gracey directly holds 5,025 shares of Omada Health common stock. This post-transaction holding reflects her remaining equity stake after selling 2,083 shares in an open-market trade executed on June 24, 2026.

Was the Omada Health insider sale by Craig Gracey under a 10b5-1 plan?

Yes. The filing states the sale was made under a Rule 10b5-1 trading plan adopted by Craig Gracey on March 13, 2026. Such plans pre-schedule trades, meaning the timing is predetermined rather than based on short-term market or company developments.

What type of transaction is shown in Omada Health’s latest Form 4 for OMDA?

The Form 4 reports an open-market sale of Omada Health common stock by Chief Accounting Officer Craig Gracey. The transaction used code “S,” indicating a sale in the open market or private transaction, totaling 2,083 shares at a weighted average price of $19.0118.

How many Omada Health (OMDA) shares did Craig Gracey sell according to the Form 4?

According to the Form 4, Craig Gracey sold 2,083 shares of Omada Health common stock. These shares were sold in multiple trades on June 24, 2026, at prices ranging from $19.00 to $19.03, with the weighted average reported as $19.0118 per share.